
    
      Syntropin will be administered by subcutaneous injection. Eligible patients will receive a
      subcutaneous injection of octreodite (to suppress endogenous growth hormone secretion) 12
      hours before, immediately prior to, and 12 hours after the scheduled injection of growth
      hormone.
    
  